Soma Neuroscience is a biotechnology company developing ibogaine-based therapeutics for trauma, substance use disorders and related conditions. Our work integrates clinical research, drug development and real world evidence to explore the therapeutic potential of ibogaine while prioritizing safety, scientific rigor, and responsible development.